Article
Topical anti-allergic medications do not induce the ocular drying characteristic of systemic antihistamines.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Q&A: Natalie Afshari, MD, FACS, championing on-label pediatric IOLs: turning advocacy into access
ROP: Treating and preventing blindness in preterm babies
Study links secondhand smoke exposure to increased myopia risk in children
Managing a changing landscape of IRD pediatric cases
European Commission approves low-dose atropine eye drop Ryjunea from Santen
ViGeneron rebrands as VeonGen Therapeutics, announces rare pediatric disease designation for VG801